10-Q Filing

CELLDEX THERAPEUTICS, INC. CIK: 744218 Q2 2013

Filing Information

Form Type	10-Q
Accession Number	`0001104659-13-060226`
Period End Date	20130630
Filing Date	20130806
Fiscal Year	2013
Fiscal Period	Q2
XBRL Instance	cldx-20130630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 69 Income Statement 74 Cash Flow Statement 62

Balance Sheet 69 line items

Line Item	Tag	Value	Unit	Period
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Par Value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Convertible Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$25.90M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.56M	USD	Point-in-time
Convertible Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$129.08M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable Securities	`AvailableForSaleSecuritiesDebtSecuritiesCurrent`	$59.06M	USD	Point-in-time
Convertible Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$44.00K	USD	Point-in-time
Common Stock, Par Value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Accounts and Other Receivables	`AccountsAndOtherReceivablesNetCurrent`	$12.00K	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.11M	USD	Point-in-time
Prepaid and Other Current Assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.44M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	297.00M	shares	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	80.98M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$156.43M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$85.11M	USD	Point-in-time
Common Stock, Shares Issued	`CommonStockSharesIssued`	64.36M	shares	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	80.98M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$7.34M	USD	Point-in-time
Common Stock, Shares Outstanding	`CommonStockSharesOutstanding`	64.36M	shares	Point-in-time
Property and Equipment, Net	`PropertyPlantAndEquipmentNet`	$7.21M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$23.33M	USD	Point-in-time
Intangible Assets, Net	`IntangibleAssetsNetExcludingGoodwill`	$23.83M	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$424.00K	USD	Point-in-time
Other Assets	`OtherAssetsNoncurrent`	$174.00K	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Goodwill	`Goodwill`	$8.96M	USD	Point-in-time
Total Assets	`Assets`	$196.23M	USD	Point-in-time
Total Assets	`Assets`	$125.54M	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$745.00K	USD	Point-in-time
Accounts Payable	`AccountsPayableCurrent`	$2.07M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$9.90M	USD	Point-in-time
Accrued Expenses	`AccruedLiabilitiesCurrent`	$10.96M	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$530.00K	USD	Point-in-time
Current Portion of Long-Term Liabilities	`OtherLiabilitiesCurrent`	$388.00K	USD	Point-in-time
Current Portion of Term Loan	`SecuredDebtCurrent`	$5.59M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$17.68M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$12.50M	USD	Point-in-time
Term Loan, less Current Portion	`SecuredLongTermDebt`	$5.75M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.34M	USD	Point-in-time
Other Long-Term Liabilities	`OtherLiabilitiesNoncurrent`	$6.64M	USD	Point-in-time
Total Liabilities	`Liabilities`	$19.14M	USD	Point-in-time
Total Liabilities	`Liabilities`	$29.77M	USD	Point-in-time
Commitments and Contingent Liabilities (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingent Liabilities (Note 13)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2013 and December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2013 and December 31, 2012	`PreferredStockValue`	-	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 80,977,696 and 64,359,513 Shares Issued and Outstanding at June 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$81.00K	USD	Point-in-time
Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 80,977,696 and 64,359,513 Shares Issued and Outstanding at June 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$64.00K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$357.09M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$474.94M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.69M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.75M	USD	Point-in-time
Accumulated Other Comprehensive Income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$2.55M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-300.48M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-264.13M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$95.77M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$177.09M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$125.54M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$196.23M	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$40.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$47.00K	USD	1 Quarter
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$77.00K	USD	2 Qtrs
Product Development and Licensing Agreements	`RevenueFromProductDevelopmentAndLicensingAgreements`	$75.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$100.00K	USD	2 Qtrs
Contracts and Grants	`RevenueFromContractsAndGrants`	$96.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$50.00K	USD	1 Quarter
Contracts and Grants	`RevenueFromContractsAndGrants`	$149.00K	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$4.22M	USD	2 Qtrs
Product Royalties	`RoyaltyRevenue`	$1.87M	USD	1 Quarter
Product Royalties	`RoyaltyRevenue`	$2.33M	USD	2 Qtrs
Total Revenue	`Revenues`	$4.44M	USD	2 Qtrs
Total Revenue	`Revenues`	$97.00K	USD	1 Quarter
Total Revenue	`Revenues`	$2.01M	USD	1 Quarter
Total Revenue	`Revenues`	$2.51M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$11.11M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$15.09M	USD	1 Quarter
Research and Development	`ResearchAndDevelopmentExpense`	$21.88M	USD	2 Qtrs
Research and Development	`ResearchAndDevelopmentExpense`	$29.18M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$2.33M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$4.22M	USD	2 Qtrs
Royalty	`RoyaltyExpense`	$1.87M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$6.55M	USD	2 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$3.41M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$2.22M	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$4.54M	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$291.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Acquired Intangible Assets	`AmortizationOfIntangibleAssets`	$583.00K	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$18.75M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$38.57M	USD	2 Qtrs
Total Operating Expense	`CostsAndExpenses`	$15.50M	USD	1 Quarter
Total Operating Expense	`CostsAndExpenses`	$31.22M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-36.06M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-13.49M	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-26.78M	USD	2 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-18.66M	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$161.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$540.00K	USD	2 Qtrs
Investment and Other Income, Net	`InterestAndOtherIncome`	$126.00K	USD	1 Quarter
Investment and Other Income, Net	`InterestAndOtherIncome`	$331.00K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$519.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$411.00K	USD	1 Quarter
Interest Expense	`InterestExpense`	$844.00K	USD	2 Qtrs
Interest Expense	`InterestExpense`	$829.00K	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-27.29M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.35M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.02M	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.47	USD	2 Qtrs
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.24	USD	1 Quarter
Basic and Diluted Net Loss Per Common Share (Note 3) (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.50	USD	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	58.73M	shares	1 Quarter
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	77.48M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	54.44M	shares	2 Qtrs
Shares Used in Calculating Basic and Diluted Net Loss per Share (Note 3) (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	80.90M	shares	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-27.29M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.35M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.02M	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$1.00K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	1 Quarter
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-3.00K	USD	2 Qtrs
Foreign Currency Translation Adjustments	`OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent`	$-1.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-39.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-194.00K	USD	2 Qtrs
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-140.00K	USD	1 Quarter
Unrealized (Loss) Gain on Marketable Securities	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$69.00K	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-13.81M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-36.55M	USD	2 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-19.16M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-27.22M	USD	2 Qtrs

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-27.29M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-36.35M	USD	2 Qtrs
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-13.77M	USD	1 Quarter
Net Loss	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-19.02M	USD	1 Quarter
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$1.07M	USD	2 Qtrs
Depreciation and Amortization	`DepreciationDepletionAndAmortization`	$943.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$291.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$507.00K	USD	2 Qtrs
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$254.00K	USD	1 Quarter
Amortization of Intangible Assets	`AmortizationOfIntangibleAssets`	$583.00K	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$1.95M	USD	2 Qtrs
Amortization and Premium of Marketable Securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$157.00K	USD	2 Qtrs
Realized Gain on Sales and Maturities of Marketable Securities	`MarketableSecuritiesGainLoss`	$6.00K	USD	2 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$21.00K	USD	2 Qtrs
Gain on Sale or Disposal of Assets	`GainLossOnSaleOfPropertyPlantEquipment`	$12.00K	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.09M	USD	2 Qtrs
Stock-Based Compensation Expense	`ShareBasedCompensation`	$1.38M	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$111.00K	USD	2 Qtrs
Non-Cash Interest Expense	`AmortizationOfDebtDiscountPremium`	$97.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-109.00K	USD	2 Qtrs
Accounts and Other Receivables	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-32.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$493.00K	USD	2 Qtrs
Prepaid and Other Current Assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$424.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$-250.00K	USD	2 Qtrs
Other Assets	`IncreaseDecreaseInOtherOperatingAssets`	$99.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-993.00K	USD	2 Qtrs
Accounts Payable and Accrued Expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$109.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$162.00K	USD	2 Qtrs
Other Liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$573.00K	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-35.26M	USD	2 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-25.51M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$20.92M	USD	2 Qtrs
Sales and Maturities of Marketable Securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$20.58M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$39.38M	USD	2 Qtrs
Purchases of Marketable Securities	`PaymentsToAcquireMarketableSecurities`	$88.84M	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$122.00K	USD	2 Qtrs
Acquisition of Property and Equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$917.00K	USD	2 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$21.00K	USD	2 Qtrs
Proceeds from Sale or Disposal of Assets	`ProceedsFromSaleOfProductiveAssets`	$156.00K	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-18.43M	USD	2 Qtrs
Net Cash Used in Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-69.16M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$114.19M	USD	2 Qtrs
Net Proceeds from Stock Issuances	`ProceedsFromIssuanceOfCommonStock`	$51.96M	USD	2 Qtrs
Proceeds from Issuance of Stock from Employee Benefit Plans	`ProceedsFromStockPlans`	$2.29M	USD	2 Qtrs
Payments of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$-1.32M	USD	2 Qtrs
Payments of Term Loan	`ProceedsFromIssuanceOfLongTermDebt`	$-11.03M	USD	2 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$29.00K	USD	2 Qtrs
Payments of Other Liabilities	`RepaymentsOfOtherLongTermDebt`	$29.00K	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$50.60M	USD	2 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$105.42M	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$-3.00K	USD	2 Qtrs
Effect of Exchange Rate Changes on Cash and Cash Equivalents	`EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations`	$1.00K	USD	2 Qtrs
Net Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$6.66M	USD	2 Qtrs
Net Increase in Cash and Cash Equivalents	`NetCashProvidedByUsedInContinuingOperations`	$1.00M	USD	2 Qtrs
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$25.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents at Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.56M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$25.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$11.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$24.90M	USD	Point-in-time
Cash and Cash Equivalents at End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.56M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.